Brachial-basilic arteriovenous fistula versus arteriovenous graft in vascular access for maintenance hemodialysis patients
Gao, M.; Tang, R.-n.; Yang, J.-f.; Zhang, L.-p.; Wang, Y.; Liu, H.; Tu, Y.; Liu, B.-c.
Zhonghua Yi Xue Za Zhi 93(15): 1150-1152
2013
ISSN/ISBN: 0376-2491 PMID: 23902884 Document Number: 667889
To compared the outcomes of autogenous brachial-basilic arteriovenous fistula (BBAVF) and AV graft (AVG) in patients undergoing long-term hemodialysis. Approved by Zhong Da hospital ethics committee, we analyzed 61 complex patients, 30 randomized to receive AVG and 31 received BBAVF. We compared patency rates of BBAVF and AVG in 3 months, 1 year, 2 years, 3 years, and complication rates. Patency rates of BBAVF in 3 months, 1 year, 2 years, 3 years were 100%, 96.8%, 90.3%, 87.1%, 3 years accumulative total infection rate was 3.2%, thrombosis rate was 3.2%. Patency rates of AVG in 3 months, 1 year, 2 years, 3 years were 96.7%, 50.0%, 36.7%, 33.3%, 3 years accumulative total infection rate was 26.7%, thrombosis rate was 33.3%. Patency rates of BBAVF in 1 year, 2 years, 3 years were higher than patency rates of AVG. The complication rates of infection and thrombosis were significantly lower for BBAVF than for AVG (P < 0.05, respectively). BBAVF has the advantage of a higher patency rate, a lower complication rates of infection and thrombosis, should be served as a favourable choice in building the vascular access in maintenance hemodialysis patients.